UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
复制标题
通过小鼠背气囊试验确定,UFT 及其代谢物可抑制小鼠肾细胞癌诱导的血管生成。
DOI:
--
复制
发表时间:
1999
影响因子:
11.5
通讯作者:
Yuji Yamada
中科院分区:
文献类型:
--
作者:
K. Yonekura;Y. Basaki;L. Chikahisa;S. Okabe;A. Hashimoto;K. Miyadera;K. Wierzba;Yuji Yamada
UFT, an anticancer agent that is composed of tegafur (FT) and uracil at a molar ratio of 1:4, is widely used in clinical practice in Japan to treat cancer patients requiring a long-term chemotherapy, and it is associated with few side effects, if any. In this study, we have evaluated the inhibitory effect of UFT against RENCA cell-induced angiogenesis by a dorsal air sac assay. Marked angiogenesis is induced by implantation of a chamber containing RENCA cells into mice. In this model, UFT showed a strong angiogenesis-inhibitory effect, whereas 5-fluorouracil (5-FU) and doxifluridine were less effective. Additional experiments revealed FT to be effective component of UFT; uracil remained ineffective in the inhibition of angiogenesis. Moreover, we have found that gamma-hydroxybutyric acid and gamma-butyrolactone, the metabolites of FT, possess a potent angiogenesis inhibitory effect that is amplified when the compounds are administered by a continuous infusion. This may reflect a transition in blood concentration of each metabolite resulting from the administration of UFT. Similar results were also obtained with respect to 5-FU. It was suggested that UFT has a stronger angiogenesis-inhibitory effect than did other fluorinated pyrimidines, partly due to its pharmacokinetic properties characterized by maintaining of higher and long-lasting blood levels of 5-FU and partly due the inhibitory effects derived from gamma-hydroxybutyric acid and gamma-butyrolactone, UFT-specific metabolites.
DOI:
--
发表时间:
1997
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research.
影响因子:
--
作者:
Kurebayashi,J;Nukatsuka,M;Fujioka,A;Saito,H;Takeda,S;Unemi,N;Fukumori,H;Kurosumi,M;Sonoo,H;Dickson,RB
通讯作者:
Dickson,RB
影响因子:
56.9
作者:
Jan Thompson;Anderson Kd;JM DiPietro;J. Zwiebel;M. Zametta;W. Anderson;T. Maciag
通讯作者:
Jan Thompson;Anderson Kd;JM DiPietro;J. Zwiebel;M. Zametta;W. Anderson;T. Maciag
影响因子:
3.1
作者:
NGUYEN, M;SHING, Y;FOLKMAN, J
通讯作者:
FOLKMAN, J